{"entity":{"type":"insider","cik":"0001734817","url":"/insider/0001734817","json_url":"/insider/0001734817.json","name":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":83,"n_filings":23,"first":"2020-07-29","last":"2026-01-14","span_basis":"filed_date"},"name_variants":[{"name":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","source":"filing","n_filings":23,"first_seen":"2020-07-29","last_seen":"2026-01-14"}],"transactions":[{"id":6118631,"accession":"0001231919-26-000057","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231919-26-000057","line_url":"/filing/0001231919-26-000057#line-4","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"Aktis Oncology, Inc.","issuer_ticker":"AKTS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM ONCOLOGY INNOVATIONS FUND LP; MPM Oncology Innovations Fund GP LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2018 LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; EVNIN LUKE; MPM BioVentures 2018 GP LLC","owner_display_name":"MPM ONCOLOGY INNOVATIONS FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1112777.0,"shares_display":"1,112,777","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":20029986.0,"total_display":"20,029,986.00","total_whole":"20,029,986","shares_owned_after":10260064.0,"shares_owned_after_display":"10,260,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":4861298,"accession":"0001415889-25-013248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-013248","line_url":"/filing/0001415889-25-013248#line-1","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 GP LLC; Foley Todd; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; EVNIN LUKE; MPM BioVentures 2014 LLC","owner_display_name":"MPM Asset Management Investors BV2014 LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":630191.0,"shares_display":"630,191","price_per_share":8.06,"price_display":"8.06","price_state":"stated","total_value":5079339.46,"total_display":"5,079,339.46","total_whole":"5,079,339","shares_owned_after":2108594.0,"shares_owned_after_display":"2,108,594","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-13","filed_date":"2025-05-15","scope":"insider"},{"id":2371463,"accession":"0001415889-24-029141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029141","line_url":"/filing/0001415889-24-029141#line-2","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BIOVENTURES 2018 (B), L.P.; GADICKE ANSBERT; MPM Asset Management Investors BV2014 LLC; Foley Todd; MPM BioVentures 2014 GP LLC; EVNIN LUKE","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21787.0,"shares_display":"21,787","price_per_share":20.23,"price_display":"20.23","price_state":"stated","total_value":440751.01,"total_display":"440,751.01","total_whole":"440,751","shares_owned_after":4381062.0,"shares_owned_after_display":"4,381,062","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-12","scope":"insider"},{"id":2371461,"accession":"0001415889-24-029141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-029141","line_url":"/filing/0001415889-24-029141#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BIOVENTURES 2018 (B), L.P.; GADICKE ANSBERT; MPM Asset Management Investors BV2014 LLC; Foley Todd; MPM BioVentures 2014 GP LLC; EVNIN LUKE","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22935.0,"shares_display":"22,935","price_per_share":20.77,"price_display":"20.77","price_state":"stated","total_value":476359.95,"total_display":"476,359.95","total_whole":"476,360","shares_owned_after":4402849.0,"shares_owned_after_display":"4,402,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-12","scope":"insider"},{"id":6692851,"accession":"0001209191-22-002168","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-002168","line_url":"/filing/0001209191-22-002168#line-5","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"Foley Todd; MPM BioVentures 2014 LLC; MPM BioVentures 2014 (B), L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 GP LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014, L.P.; EVNIN LUKE","owner_display_name":"Foley Todd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18135.0,"shares_display":"18,135","price_per_share":42.03,"price_display":"42.03","price_state":"stated","total_value":762214.05,"total_display":"762,214.05","total_whole":"762,214","shares_owned_after":2738785.0,"shares_owned_after_display":"2,738,785","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-06","scope":"insider"},{"id":6692849,"accession":"0001209191-22-002168","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-002168","line_url":"/filing/0001209191-22-002168","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"Foley Todd; MPM BioVentures 2014 LLC; MPM BioVentures 2014 (B), L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 GP LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014, L.P.; EVNIN LUKE","owner_display_name":"Foley Todd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128550.0,"shares_display":"128,550","price_per_share":42.65916437183975,"price_display":"42.66","price_state":"stated","total_value":5483835.58,"total_display":"5,483,835.58","total_whole":"5,483,836","shares_owned_after":2790725.0,"shares_owned_after_display":"2,790,725","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-06","scope":"insider","n_lines":4},{"id":5173204,"accession":"0001209191-21-068408","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-21-068408","line_url":"/filing/0001209191-21-068408","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 GP LLC; EVNIN LUKE; MPM BioVentures 2014 LLC; Foley Todd; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BioVentures 2014 (B), L.P.","owner_display_name":"MPM Asset Management Investors BV2014 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19456.0,"shares_display":"19,456","price_per_share":33.223717105263155,"price_display":"33.22","price_state":"stated","total_value":646400.64,"total_display":"646,400.64","total_whole":"646,401","shares_owned_after":2886964.0,"shares_owned_after_display":"2,886,964","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-07","filed_date":"2021-12-07","scope":"insider","n_lines":2},{"id":5173196,"accession":"0001209191-21-068408","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-068408","line_url":"/filing/0001209191-21-068408","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 GP LLC; EVNIN LUKE; MPM BioVentures 2014 LLC; Foley Todd; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BioVentures 2014 (B), L.P.","owner_display_name":"MPM Asset Management Investors BV2014 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10208.0,"shares_display":"10,208","price_per_share":32.59185540752351,"price_display":"32.59","price_state":"stated","total_value":332697.66,"total_display":"332,697.66","total_whole":"332,698","shares_owned_after":2906665.0,"shares_owned_after_display":"2,906,665","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider","n_lines":4},{"id":5173178,"accession":"0001209191-21-068408","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-068408","line_url":"/filing/0001209191-21-068408","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 GP LLC; EVNIN LUKE; MPM BioVentures 2014 LLC; Foley Todd; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BioVentures 2014 (B), L.P.","owner_display_name":"MPM Asset Management Investors BV2014 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20167.0,"shares_display":"20,167","price_per_share":34.78518470769078,"price_display":"34.79","price_state":"stated","total_value":701512.82,"total_display":"701,512.82","total_whole":"701,513","shares_owned_after":2917732.0,"shares_owned_after_display":"2,917,732","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-07","scope":"insider","n_lines":3},{"id":4437038,"accession":"0001209191-21-067706","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-067706","line_url":"/filing/0001209191-21-067706","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014, L.P.; Foley Todd; MPM BioVentures 2014 GP LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 LLC; EVNIN LUKE","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37187.0,"shares_display":"37,187","price_per_share":33.95778309624331,"price_display":"33.96","price_state":"stated","total_value":1262788.08,"total_display":"1,262,788.08","total_whole":"1,262,788","shares_owned_after":2942731.0,"shares_owned_after_display":"2,942,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-02","scope":"insider","n_lines":2},{"id":4437031,"accession":"0001209191-21-067706","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-067706","line_url":"/filing/0001209191-21-067706","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014, L.P.; Foley Todd; MPM BioVentures 2014 GP LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 LLC; EVNIN LUKE","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12395.0,"shares_display":"12,395","price_per_share":34.277680516337234,"price_display":"34.28","price_state":"stated","total_value":424871.85,"total_display":"424,871.85","total_whole":"424,872","shares_owned_after":2978841.0,"shares_owned_after_display":"2,978,841","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-02","scope":"insider","n_lines":3},{"id":4437017,"accession":"0001209191-21-067706","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-067706","line_url":"/filing/0001209191-21-067706","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014, L.P.; Foley Todd; MPM BioVentures 2014 GP LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 LLC; EVNIN LUKE","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33937.0,"shares_display":"33,937","price_per_share":35.09155965465421,"price_display":"35.09","price_state":"stated","total_value":1190902.26,"total_display":"1,190,902.26","total_whole":"1,190,902","shares_owned_after":2984883.0,"shares_owned_after_display":"2,984,883","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-02","scope":"insider","n_lines":2},{"id":5437829,"accession":"0001209191-21-067148","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-067148","line_url":"/filing/0001209191-21-067148","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; EVNIN LUKE; MPM BioVentures 2014 GP LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; Foley Todd; MPM BioVentures 2014 LLC; MPM BIOVENTURES 2018 (B), L.P.","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10371.0,"shares_display":"10,371","price_per_share":34.486147912448175,"price_display":"34.49","price_state":"stated","total_value":357655.84,"total_display":"357,655.84","total_whole":"357,656","shares_owned_after":3019118.0,"shares_owned_after_display":"3,019,118","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-11-30","scope":"insider","n_lines":2},{"id":5437825,"accession":"0001209191-21-067148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-067148","line_url":"/filing/0001209191-21-067148","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; EVNIN LUKE; MPM BioVentures 2014 GP LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; Foley Todd; MPM BioVentures 2014 LLC; MPM BIOVENTURES 2018 (B), L.P.","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12674.0,"shares_display":"12,674","price_per_share":35.751137762348115,"price_display":"35.75","price_state":"stated","total_value":453109.92,"total_display":"453,109.92","total_whole":"453,110","shares_owned_after":3035320.0,"shares_owned_after_display":"3,035,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-30","scope":"insider","n_lines":2},{"id":5300121,"accession":"0001209191-21-066852","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-066852","line_url":"/filing/0001209191-21-066852","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 LLC; Foley Todd; MPM BioVentures 2014, L.P.; MPM BioVentures 2014 GP LLC; MPM BIOVENTURES 2018 (B), L.P.; EVNIN LUKE; MPM Asset Management Investors BV2014 LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36337.0,"shares_display":"36,337","price_per_share":36.28651980075405,"price_display":"36.29","price_state":"stated","total_value":1318543.27,"total_display":"1,318,543.27","total_whole":"1,318,543","shares_owned_after":3054991.0,"shares_owned_after_display":"3,054,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-24","scope":"insider","n_lines":3},{"id":5300114,"accession":"0001209191-21-066852","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-066852","line_url":"/filing/0001209191-21-066852","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 LLC; Foley Todd; MPM BioVentures 2014, L.P.; MPM BioVentures 2014 GP LLC; MPM BIOVENTURES 2018 (B), L.P.; EVNIN LUKE; MPM Asset Management Investors BV2014 LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20004.0,"shares_display":"20,004","price_per_share":36.21520445910818,"price_display":"36.22","price_state":"stated","total_value":724448.95,"total_display":"724,448.95","total_whole":"724,449","shares_owned_after":3078561.0,"shares_owned_after_display":"3,078,561","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-24","scope":"insider","n_lines":2},{"id":5300109,"accession":"0001209191-21-066852","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-066852","line_url":"/filing/0001209191-21-066852","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 LLC; Foley Todd; MPM BioVentures 2014, L.P.; MPM BioVentures 2014 GP LLC; MPM BIOVENTURES 2018 (B), L.P.; EVNIN LUKE; MPM Asset Management Investors BV2014 LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21114.0,"shares_display":"21,114","price_per_share":37.52348157620536,"price_display":"37.52","price_state":"stated","total_value":792270.79,"total_display":"792,270.79","total_whole":"792,271","shares_owned_after":3098206.0,"shares_owned_after_display":"3,098,206","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-24","scope":"insider","n_lines":2},{"id":4587910,"accession":"0001209191-21-062982","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-062982","line_url":"/filing/0001209191-21-062982#line-3","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"Entrada Therapeutics, Inc.","issuer_ticker":"TRDA","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"MPM BioVentures 2014 LLC; MPM Asset Management Investors BV2014 LLC; GADICKE ANSBERT; EVNIN LUKE; MPM BioVentures 2014, L.P.; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","owner_display_name":"MPM BioVentures 2014 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":2000000.0,"total_display":"2,000,000.00","total_whole":"2,000,000","shares_owned_after":4425784.0,"shares_owned_after_display":"4,425,784","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-04","scope":"insider"},{"id":4676714,"accession":"0001209191-21-060723","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-060723","line_url":"/filing/0001209191-21-060723#line-3","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014, L.P.; Foley Todd; MPM BioVentures 2014 LLC; EVNIN LUKE; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 (B), L.P.; MPM Asset Management Investors BV2014 LLC","owner_display_name":"MPM BioVentures 2014, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6167.0,"shares_display":"6,167","price_per_share":27.14,"price_display":"27.14","price_state":"stated","total_value":167372.38,"total_display":"167,372.38","total_whole":"167,372","shares_owned_after":3134991.0,"shares_owned_after_display":"3,134,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-18","scope":"insider"},{"id":4676706,"accession":"0001209191-21-060723","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-060723","line_url":"/filing/0001209191-21-060723","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014, L.P.; Foley Todd; MPM BioVentures 2014 LLC; EVNIN LUKE; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 (B), L.P.; MPM Asset Management Investors BV2014 LLC","owner_display_name":"MPM BioVentures 2014, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10932.0,"shares_display":"10,932","price_per_share":27.61952799121844,"price_display":"27.62","price_state":"stated","total_value":301936.68,"total_display":"301,936.68","total_whole":"301,937","shares_owned_after":3143197.0,"shares_owned_after_display":"3,143,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-18","scope":"insider","n_lines":2},{"id":5430832,"accession":"0001209191-21-060490","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-060490","line_url":"/filing/0001209191-21-060490#line-3","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; EVNIN LUKE; MPM BioVentures 2014 GP LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; Foley Todd; MPM BioVentures 2014 LLC; MPM BIOVENTURES 2018 (B), L.P.","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27320.0,"shares_display":"27,320","price_per_share":27.3,"price_display":"27.30","price_state":"stated","total_value":745836.0,"total_display":"745,836.00","total_whole":"745,836","shares_owned_after":3152090.0,"shares_owned_after_display":"3,152,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-14","scope":"insider"},{"id":5430829,"accession":"0001209191-21-060490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-060490","line_url":"/filing/0001209191-21-060490#line-2","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; EVNIN LUKE; MPM BioVentures 2014 GP LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; Foley Todd; MPM BioVentures 2014 LLC; MPM BIOVENTURES 2018 (B), L.P.","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20929.0,"shares_display":"20,929","price_per_share":27.13,"price_display":"27.13","price_state":"stated","total_value":567803.77,"total_display":"567,803.77","total_whole":"567,804","shares_owned_after":3179410.0,"shares_owned_after_display":"3,179,410","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-13","filed_date":"2021-10-14","scope":"insider"},{"id":5430825,"accession":"0001209191-21-060490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060490","line_url":"/filing/0001209191-21-060490#line-1","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; EVNIN LUKE; MPM BioVentures 2014 GP LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; Foley Todd; MPM BioVentures 2014 LLC; MPM BIOVENTURES 2018 (B), L.P.","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8521.0,"shares_display":"8,521","price_per_share":27.09,"price_display":"27.09","price_state":"stated","total_value":230833.89,"total_display":"230,833.89","total_whole":"230,834","shares_owned_after":3200339.0,"shares_owned_after_display":"3,200,339","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-12","filed_date":"2021-10-14","scope":"insider"},{"id":4956608,"accession":"0001209191-21-060236","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-060236","line_url":"/filing/0001209191-21-060236#line-3","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BioVentures 2014 LLC; Foley Todd; EVNIN LUKE; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014, L.P.; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.","owner_display_name":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48812.0,"shares_display":"48,812","price_per_share":27.24,"price_display":"27.24","price_state":"stated","total_value":1329638.88,"total_display":"1,329,638.88","total_whole":"1,329,639","shares_owned_after":3208860.0,"shares_owned_after_display":"3,208,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-11","filed_date":"2021-10-12","scope":"insider"},{"id":4956603,"accession":"0001209191-21-060236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-060236","line_url":"/filing/0001209191-21-060236#line-2","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BioVentures 2014 LLC; Foley Todd; EVNIN LUKE; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014, L.P.; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.","owner_display_name":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2032.0,"shares_display":"2,032","price_per_share":27.01,"price_display":"27.01","price_state":"stated","total_value":54884.32,"total_display":"54,884.32","total_whole":"54,884","shares_owned_after":3257672.0,"shares_owned_after_display":"3,257,672","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-08","filed_date":"2021-10-12","scope":"insider"},{"id":4956595,"accession":"0001209191-21-060236","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060236","line_url":"/filing/0001209191-21-060236#line-1","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BioVentures 2014 LLC; Foley Todd; EVNIN LUKE; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014, L.P.; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.","owner_display_name":"MPM ASSET MANAGEMENT INVESTORS BV2018 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1149.0,"shares_display":"1,149","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":31023.0,"total_display":"31,023.00","total_whole":"31,023","shares_owned_after":3259704.0,"shares_owned_after_display":"3,259,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-07","filed_date":"2021-10-12","scope":"insider"},{"id":5500344,"accession":"0001209191-21-059426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-059426","line_url":"/filing/0001209191-21-059426#line-2","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 LLC; Foley Todd; EVNIN LUKE; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BioVentures 2014 GP LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.","owner_display_name":"MPM BioVentures 2014 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20711.0,"shares_display":"20,711","price_per_share":27.06,"price_display":"27.06","price_state":"stated","total_value":560439.66,"total_display":"560,439.66","total_whole":"560,440","shares_owned_after":3260853.0,"shares_owned_after_display":"3,260,853","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-05","scope":"insider"},{"id":5500342,"accession":"0001209191-21-059426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-059426","line_url":"/filing/0001209191-21-059426#line-1","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 LLC; Foley Todd; EVNIN LUKE; MPM BioVentures 2014, L.P.; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM BioVentures 2014 GP LLC; MPM Asset Management Investors BV2014 LLC; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014 (B), L.P.","owner_display_name":"MPM BioVentures 2014 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6855.0,"shares_display":"6,855","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":185085.0,"total_display":"185,085.00","total_whole":"185,085","shares_owned_after":3281564.0,"shares_owned_after_display":"3,281,564","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider"},{"id":5298648,"accession":"0001209191-21-058209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-058209","line_url":"/filing/0001209191-21-058209#line-2","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014, L.P.; Foley Todd; EVNIN LUKE; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014 GP LLC","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2292.0,"shares_display":"2,292","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":61884.0,"total_display":"61,884.00","total_whole":"61,884","shares_owned_after":3288419.0,"shares_owned_after_display":"3,288,419","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-30","filed_date":"2021-09-30","scope":"insider"},{"id":5298645,"accession":"0001209191-21-058209","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-058209","line_url":"/filing/0001209191-21-058209#line-1","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"MPM BioVentures 2014 (B), L.P.; MPM BIOVENTURES 2018 (B), L.P.; MPM BioVentures 2014, L.P.; Foley Todd; EVNIN LUKE; MPM ASSET MANAGEMENT INVESTORS BV2018 LLC; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014 GP LLC","owner_display_name":"MPM BioVentures 2014 (B), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19214.0,"shares_display":"19,214","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":518778.0,"total_display":"518,778.00","total_whole":"518,778","shares_owned_after":3290711.0,"shares_owned_after_display":"3,290,711","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-28","filed_date":"2021-09-30","scope":"insider"}],"collapsed":true,"next_cursor":"2021-09-28|5298645","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002035832","name":"Aktis Oncology, Inc.","url":"/issuer/0002035832","role":"Ten percent owner","n_filings":1,"first_seen":"2026-01-14","last_seen":"2026-01-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001808865","name":"iTeos Therapeutics, Inc.","url":"/issuer/0001808865","role":"Ten percent owner, Other","n_filings":20,"first_seen":"2020-07-29","last_seen":"2025-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001689375","name":"Entrada Therapeutics, Inc.","url":"/issuer/0001689375","role":"Ten percent owner","n_filings":2,"first_seen":"2021-11-04","last_seen":"2024-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001734817","retrieved_at":"2026-08-22T18:49:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}